NCT03260192View on ClinicalTrials.gov

Circulating Tumor DNA to Monitor Response to Neoadjuvant Chemotherapy in Breast Cancer

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

September 1, 2013

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Breast Cancer
Trial Locations (1)

Unknown

RECRUITING

Sunyat-sen Memorial Hospital, Guandong

All Listed Sponsors
lead

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER

NCT03260192 - Circulating Tumor DNA to Monitor Response to Neoadjuvant Chemotherapy in Breast Cancer | Biotech Hunter | Biotech Hunter